Nuclear stocks are getting hit hard Thursday even as the long-term case for atomic power looks stronger than ever, and the reasons behind the selloff reveal a tension that could keep the sector volatile for months.

Nuclear energy is making a comeback, and two American companies are poised to flourish as the industry landscape evolves.

XE strengthens its fuel and supply-chain capabilities with HALEU and graphite agreements as it advances the Xe-100 toward commercialization.

The only company news on the day was a board appointment, and the results that could test the price do not arrive until later in August.

Cameco's Q2 results weaken as lower uranium sales and Westinghouse earnings weigh on growth, but firm uranium prices support its longer-term outlook.

Oklo's nuclear opportunity is expanding, but rising spending and execution risks cloud its path to recurring power revenues.

Centrus Energy’s second quarter saw revenue growth driven by higher commercial activity in both its low-enriched uranium (LEU) and high-assay low-enriched uranium (HALEU) markets, but profitability came under pressure as operating margin contracted sharply year-on-year. Management pointed to increased spending on workforce expansion, manufacturing readiness, and advanced technology costs as key factors behind the margin decline. CEO Amir Vexler acknowledged the variability in quarterly results a

X-Energy (NASDAQ:XE) reported second-quarter 2026 revenue and grant income of $54.6 million, up 154% from a year earlier, as engineering activity increased under the U.S. Department of Energy’s Advanced Reactor Demonstration Program, or ARDP. CEO Clay Sell also said the Department of Energy formall

Uranium revenue surged while backlog hit $4.5 billion, but HALEU funding faces uncertainty.

Energy Fuels' uranium growth and rare earth expansion offer long-term potential, but a stretched valuation and expected 2026 loss weigh on its near-term appeal.

Nuclear fuel supplier Centrus Energy (NYSE:LEU) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 14% year on year to $176.1 million. Its non-GAAP profit of $0.77 per share was 4.9% below analysts’ consensus estimates.

Centrus Energy (NYSE:LEU) signed a definitive enrichment services contract with X-energy LLC to supply fuel for advanced small modular reactor deployments. The agreement covers both low-enriched uranium and high-assay, low-enriched uranium for an initial batch of X-energy SMRs. Prepayments under the contract support Centrus Energy's domestic commercial enrichment expansion and capital program. The deal underscores Centrus Energy's role in the growing market for reliable, carbon-free nuclear...

The modeled fair value for Centrus Energy has moved lower from US$269.38 to US$257.47, signaling a trimmed price target in the latest update. This shift aligns with a Street view that is split between long term growth potential in enrichment capacity and nearer term questions around capital intensity, policy risk, and sector wide multiple pressure. As you read on, you will see how these factors feed into the evolving Centrus Energy narrative and what to watch next. Stay updated as the Fair...

What does $12 billion of market value buy when combined sales run about $12 million?

Centrus Energy (NYSE:LEU) reported second-quarter 2026 revenue growth and expanded its commercial backlog as the company advanced plans to build U.S. uranium-enrichment capacity for low-enriched uranium, or LEU, and high-assay low-enriched uranium, or HALEU. Revenue for the quarter ended June 30 ro

Centrus Energy highlights a $4.5B backlog, $900M DOE funding and a 2029 production goal as enrichment demand tightens and Piketon hiring accelerates.

Centrus Energy Corp (LEU) reports strong Q2 2026 results with revenue up 14% and a $4.5 billion backlog, driven by key HALEU agreements and a $900 million DOE task order.

Centrus Energy beats Q2 earnings and revenue estimates, but higher administrative and technology costs sharply compress margins.

Moby summary of Centrus Energy Corp.'s Q2 2026 earnings call

Nuclear fuel supplier Centrus Energy (NYSE:LEU) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 14% year on year to $176.1 million. Its GAAP profit of $0.77 per share was 7.9% above analysts’ consensus estimates.

UUUU heads into Q2 earnings with revenues expected to surge on higher uranium sales, even as it is projected to post another quarterly loss.

Centrus Energy has delivered a very large 5 year return for shareholders, yet the stock now screens as expensive on the valuation checks despite the recent share price pullback over the past year. For investors, the question is whether the current price still reflects a reasonable balance between that strong past return and what the valuation framework signals today. Over the last 5 years, Centrus Energy has returned about 6.7x for shareholders, which sets a very high bar for what comes next...

America's nuclear fuel renaissance could benefit Centrus Energy.

Centrus Energy Corp. recently faced sharply lower analyst earnings and revenue estimates for its June 2026 quarter, with consensus revisions pointing to weaker near-term performance and a negative Earnings ESP ahead of the results. This shift in expectations highlights how sensitive sentiment is to changes in projected profitability for a company seen as a key player in US nuclear fuel supply. Next, we’ll examine how these more cautious earnings revisions may influence Centrus Energy’s...

Centrus Energy (LEU) is in focus after analysts sharply lowered consensus EPS estimates and now expect year over year declines in earnings and revenue for the June 2026 quarter. See our latest analysis for Centrus Energy. The recent cut to Centrus Energy’s earnings expectations appears to align with weak momentum in the stock, with the share price down 5.87% over the past day and 24.30% over the past 90 days, while the 3 year total shareholder return remains very large. If you are tracking...

LEU's Q2 report could reflect uranium price gains offset by weaker SWU volumes and rising costs, with earnings and revenues expected to decline year over year.

Centrus Energy (LEU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

US-Saudi nuclear deal could reshape the energy landscape. See how nuclear ETFs may offer diversified exposure to companies positioned to benefit.

Centrus Energy and NuScale Power offer contrasting nuclear exposure, with revenues, backlog, valuation and commercialization shaping the comparison.

Nuclear stocks have fallen sharply in 2026 despite rising AI-driven power demand. Analyst Kuran Francis highlights Constellation Energy, Centrus Energy, and the VanEck NLR ETF as ways to play the sector's long-term buildout.

Oklo stock has plummeted in 2026, in spite of the company's positive progress. This is the buying window long-term investors have been waiting for.

The world’s energy economy is changing, for better or for worse. We are shifting away from fossil fuels and toward a model based on cleaner energy sources. While solar and wind power might get the headlines, nuclear energy almost certainly has a role in this changing energy scene.TipRanks Welcomes a New ETF – NYSE:RANK TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE. RANK tracks the perfo

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers.